ArticleDermatology and therapy2024

Response to: Letter to Editor Regarding "Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study".

A David BurdenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.